Bio Medica Laboratories IPO — Listing Performance
Bio Medica Laboratories IPO facts & figures
| Issue category | SME |
|---|---|
| Issue open date | 21 May 2026 |
| Listing date | 29 May 2026 |
| Overall subscription | 2.19x |
| Issue price | ₹139 |
| Listing-day close | ₹115.80 (-16.69%) |
| Recent market price | ₹159 (14.39% vs issue) |
| 52-week range | ₹106.15 – ₹177 |
| Identifiers | NSE: BMLL · ISIN: INE1BKA01015 |
How the listing went
Bio Medica Laboratories listed at a discount, closing its first day 16.69% below the issue price, on moderate subscription of 2.19x.
Bio Medica Laboratories against every other debut on record
- Rank in 2026: 134 of 147 NSE debuts, on a -16.69% first-day close.
- 11th percentile of 58 SME debuts in 2026 (median 4.4%).
- 9th of 9 debuts in May 2026.
- Subscribed 2.19x: 28th percentile of 166 SME issues with a figure; the 65 subscribed between 1 and 5 times closed day one a median -1.34%.
- Opened 20% below issue, then added 3.31 points to the close.
- Day-one range ₹105.65 to ₹116.75: a 7.99% swing on the issue price.
- Last close ₹159 (5 Oct 2026): 14.39% above issue, against -16.69% on day one.
- 75% up its 52-week range of ₹106.15 to ₹177.
- Priced at the top of the ₹132 to ₹139 band.
- Listed 4 calendar days after close.
- All 609 SME debuts on record: median 13.86%, 79% closed above issue.
Computed over 1144 verified NSE debuts to 5 Oct 2026 · sources